Copyright Reports & Markets. All rights reserved.

Global Alzheimer's Disease Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Alzheimer's Disease Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Donepezil
      • 1.2.2 Memantine
      • 1.2.3 Rivastigmine
    • 1.3 Market Analysis by Applications
      • 1.3.1 Early to Moderate Stages
      • 1.3.2 Moderate to Severe Stages
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Allergan
      • 2.1.1 Business Overview
      • 2.1.2 Alzheimer's Disease Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Eisai
      • 2.2.1 Business Overview
      • 2.2.2 Alzheimer's Disease Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Alzheimer's Disease Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Daiichi Sankyo
      • 2.4.1 Business Overview
      • 2.4.2 Alzheimer's Disease Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Merz Pharma
      • 2.5.1 Business Overview
      • 2.5.2 Alzheimer's Disease Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Pfizer
      • 2.6.1 Business Overview
      • 2.6.2 Alzheimer's Disease Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Johnson & Johnson
      • 2.7.1 Business Overview
      • 2.7.2 Alzheimer's Disease Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Lundbeck
      • 2.8.1 Business Overview
      • 2.8.2 Alzheimer's Disease Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Alzheimer's Disease Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Alzheimer's Disease Drug Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Alzheimer's Disease Drug Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Alzheimer's Disease Drug Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Alzheimer's Disease Drug Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Alzheimer's Disease Drug Market Analysis by Regions

    • 4.1 Global Alzheimer's Disease Drug Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Alzheimer's Disease Drug Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Alzheimer's Disease Drug Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 4.3 Europe Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 4.5 South America Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    5 North America Alzheimer's Disease Drug by Country

    • 5.1 North America Alzheimer's Disease Drug Sales, Revenue and Market Share by Country
      • 5.1.1 North America Alzheimer's Disease Drug Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Alzheimer's Disease Drug Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 5.3 Canada Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    6 Europe Alzheimer's Disease Drug by Country

    • 6.1 Europe Alzheimer's Disease Drug Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Alzheimer's Disease Drug Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Alzheimer's Disease Drug Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 6.3 UK Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 6.4 France Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 6.5 Russia Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 6.6 Italy Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Alzheimer's Disease Drug by Country

    • 7.1 Asia-Pacific Alzheimer's Disease Drug Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Alzheimer's Disease Drug Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Alzheimer's Disease Drug Revenue and Market Share by Country (2014-2019)
    • 7.2 China Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 7.3 Japan Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 7.4 Korea Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 7.5 India Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    8 South America Alzheimer's Disease Drug by Country

    • 8.1 South America Alzheimer's Disease Drug Sales, Revenue and Market Share by Country
      • 8.1.1 South America Alzheimer's Disease Drug Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Alzheimer's Disease Drug Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Alzheimer's Disease Drug by Countries

    • 9.1 Middle East and Africa Alzheimer's Disease Drug Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Alzheimer's Disease Drug Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Alzheimer's Disease Drug Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Alzheimer's Disease Drug Sales and Growth Rate (2014-2019)

    10 Global Alzheimer's Disease Drug Market Segment by Type

    • 10.1 Global Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Alzheimer's Disease Drug Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Alzheimer's Disease Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Donepezil Sales Growth and Price
      • 10.2.1 Global Donepezil Sales Growth (2014-2019)
      • 10.2.2 Global Donepezil Price (2014-2019)
    • 10.3 Memantine Sales Growth and Price
      • 10.3.1 Global Memantine Sales Growth (2014-2019)
      • 10.3.2 Global Memantine Price (2014-2019)
    • 10.4 Rivastigmine Sales Growth and Price
      • 10.4.1 Global Rivastigmine Sales Growth (2014-2019)
      • 10.4.2 Global Rivastigmine Price (2014-2019)

    11 Global Alzheimer's Disease Drug Market Segment by Application

    • 11.1 Global Alzheimer's Disease Drug Sales Market Share by Application (2014-2019)
    • 11.2 Early to Moderate Stages Sales Growth (2014-2019)
    • 11.3 Moderate to Severe Stages Sales Growth (2014-2019)

    12 Alzheimer's Disease Drug Market Forecast (2019-2024)

    • 12.1 Global Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Alzheimer's Disease Drug Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Alzheimer's Disease Drug Market Forecast (2019-2024)
      • 12.2.2 Europe Alzheimer's Disease Drug Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Alzheimer's Disease Drug Market Forecast (2019-2024)
      • 12.2.4 South America Alzheimer's Disease Drug Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Alzheimer's Disease Drug Market Forecast (2019-2024)
    • 12.3 Alzheimer's Disease Drug Market Forecast by Type (2019-2024)
      • 12.3.1 Global Alzheimer's Disease Drug Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Alzheimer's Disease Drug Market Share Forecast by Type (2019-2024)
    • 12.4 Alzheimer's Disease Drug Market Forecast by Application (2019-2024)
      • 12.4.1 Global Alzheimer's Disease Drug Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Alzheimer's Disease Drug Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

      Scope of the Report:
      In the last several years, global market of alzheimer’s disease drug change huge.
      The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.
      Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.
      The worldwide market for Alzheimer's Disease Drug is expected to grow at a CAGR of roughly -11.3% over the next five years, will reach 1580 million US$ in 2024, from 2870 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Allergan
      Eisai
      Novartis
      Daiichi Sankyo
      Merz Pharma
      Pfizer
      Johnson & Johnson
      Lundbeck

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Donepezil
      Memantine
      Rivastigmine

      Market Segment by Applications, can be divided into
      Early to Moderate Stages
      Moderate to Severe Stages

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Alzheimer's Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Alzheimer's Disease Drug, with price, sales, revenue and global market share of Alzheimer's Disease Drug in 2017 and 2018.
      Chapter 3, the Alzheimer's Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Alzheimer's Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Alzheimer's Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Alzheimer's Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now